[Hepatitis C in the Netherlands: sparse data on the current prevalence and the necessity for epidemiological studies

A Kok1, F R Zuure, C J Weegink

  • 1GGD Amsterdam, cluster Infectieziekten, afd. Onderzoek, Postbus 2200, 1000 CE Amsterdam.

Insights

Hepatitis C virus (HCV) infection affects 180 million globally, potentially causing liver failure and cancer. New Dutch studies aim to understand HCV prevalence in at-risk populations.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Epidemiology

Context:

  • Hepatitis C virus (HCV) infection is a significant global health concern, with an estimated 180 million individuals infected worldwide.
  • HCV can lead to severe liver complications, including liver failure and hepatocellular carcinoma.
  • Despite improved treatments, data on HCV prevalence in the Netherlands is limited, hindering public health assessments.

Purpose:

  • To address the lack of comprehensive data on Hepatitis C virus (HCV) infection prevalence in the Netherlands.
  • To identify and inform key at-risk populations for HCV infection, as recommended by the Dutch Health Council.
  • To facilitate epidemiological studies for a better understanding of HCV's public health impact in the Netherlands.

Summary:

  • The study focuses on Hepatitis C virus (HCV), a blood-borne infection impacting millions globally and potentially causing liver failure and cancer.
  • Identified at-risk groups include injecting drug users, haemodialysis patients, haemophiliacs, individuals exposed to blood products before 1992, and those with specific medical procedure histories.
  • Several detection and epidemiological projects for HCV were initiated in the Netherlands in 2007 to improve understanding of the disease's scope.

Impact:

  • Provides crucial epidemiological insights into Hepatitis C virus (HCV) infection within the Netherlands.
  • Enables more accurate estimations of the public health burden posed by Hepatitis C.
  • Supports targeted public health interventions and resource allocation for HCV prevention and control.